NDC 51079-905-19 - Phenytoin Sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
51079-905
Requested NDC
51079-905-19
Package NDCs from labels
51079-905-01, 51079-905-20, 51079-905-19
Manufacturer
Mylan Institutional Inc.
Effective date
2022-06-14
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Phenytoin Sodium - Mylan Institutional Inc.Mylan Institutional Inc.2022-06-14HUMAN PRESCRIPTION DRUG LABEL
Phenytoin Sodium - Cardinal HealthCardinal Health2019-04-23HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2013-02-13Indexing - Billing Unit

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51079-905-01EA - Each51079-9059f2e4935-2fd5-4b5b-979e-c59f1d2c0d0a12013-02-13
51079-905-17EA - Each51079-9050542110f-30ae-4fe4-86df-d155eaa3f4ac12013-02-13
51079-905-19EA - Each51079-905672787c6-8af5-4dde-b623-1c109f18ee1012013-02-13
51079-905-20EA - Each51079-905810e26b0-89ec-4ebf-8f59-f9c7b6faee7312013-02-13
51079-905-30EA - Each51079-905ec052ee2-e856-4492-8e13-05c9ac74f19112015-12-02
51079-905-56EA - Each51079-905800d5c7c-bb3a-4041-a145-f4a704998dbe12013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PHENYTOIN SODIUMACTIVE INGREDIENT4182431BJHPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
PHENYTOIN SODIUMACTIVE INGREDIENT4182431BJHPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
PHENYTOINACTIVE MOIETY6158TKW0C5PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
PHENYTOINACTIVE MOIETY6158TKW0C5PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
D&C RED NO. 28INACTIVE INGREDIENT767IP0Y5NHPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
D&C RED NO. 28INACTIVE INGREDIENT767IP0Y5NHPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
D&C RED NO. 33INACTIVE INGREDIENT9DBA0SBB0LPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
D&C RED NO. 33INACTIVE INGREDIENT9DBA0SBB0LPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
GELATININACTIVE INGREDIENT2G86QN327LPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
GELATININACTIVE INGREDIENT2G86QN327LPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)INACTIVE INGREDIENTS38J6RZN16PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)INACTIVE INGREDIENTS38J6RZN16PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
MAGNESIUM OXIDEINACTIVE INGREDIENT3A3U0GI71GPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
MAGNESIUM OXIDEINACTIVE INGREDIENT3A3U0GI71GPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
POVIDONESINACTIVE INGREDIENTFZ989GH94EPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
POVIDONESINACTIVE INGREDIENTFZ989GH94EPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
SHELLACINACTIVE INGREDIENT46N107B71OPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
SHELLACINACTIVE INGREDIENT46N107B71OPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]5
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPPHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [CARDINAL HEALTH]5

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 145 · 2,894 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Phenytoin SodiumPHENYTOIN SODIUMHenry Schein, Inc.889dd22c-46f0-48d0-b18e-a3783c5fa6532026-11-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 4182431BJH
PHENYTOIN SODIUMPHENYTOIN SODIUMHenry Schein, Inc.a52cf1bd-dc1f-47be-aba8-29066d9a50fb2026-11-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 4182431BJH
Eyewash Station Additive ConcentrateCHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOLEncon Safety Products, Inc.b5a62567-c9f1-0492-e053-2a95a90ab2472026-11-05WarningsExact identifier
unii: 6DC9Q167V3
COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50TITANIUM DIOXIDE, ZINC OXIDECOOLA, LLCcb95c712-1680-4040-e053-2995a90af0042026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38TITANIUM DIOXIDEEai-jr 286, Inc303d5d5a-4c7a-1e23-e063-6294a90a0e582026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta BeigeTITANIUM DIOXIDEEAI-JR 286, Inc.b9ea12e8-6ed9-d805-e053-2a95a90aa1072026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Pearl White Face Stick SPF 50PADIMATE O, TITANIUM DIOXIDEEai-jr 286, Incb69a75e0-8724-35ae-e053-2a95a90a5f342026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra S Dorian Kona Gold Signature Face Stick SPF 38TITANIUM DIOXIDEEai-jr 286, Incb6c316c3-661b-6428-e053-2a95a90a1a6b2026-11-04WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 34W1TITANIUM DIOXIDEAmorepacific Corporation5f3ef340-c68e-1790-e063-6394a90a44aa2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 35C1TITANIUM DIOXIDEAmorepacific Corporation5f40c97f-b90e-bec7-e063-6394a90ae5db2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 35N1TITANIUM DIOXIDEAmorepacific Corporation5f40f46b-c6b2-df1f-e063-6394a90afd962026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 37W1TITANIUM DIOXIDEAmorepacific Corporation5f4105f3-d08b-edb5-e063-6394a90ad28b2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 39N1TITANIUM DIOXIDEAmorepacific Corporation5f41120a-521a-f5ac-e063-6394a90ac0212026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 41W1TITANIUM DIOXIDEAmorepacific Corporation5f4158f0-c743-29c2-e063-6394a90ac7212026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 43N1TITANIUM DIOXIDEAmorepacific Corporation5f41ecb2-9fe5-ade7-e063-6294a90abc4e2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 43O1TITANIUM DIOXIDEAmorepacific Corporation5f425415-ed84-fc33-e063-6394a90a15f72026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 44C1TITANIUM DIOXIDEAmorepacific Corporation5f42d960-6b86-b4cd-e063-6294a90a98f32026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 45N1TITANIUM DIOXIDEAmorepacific Corporation5f4326fc-b3c3-1a8b-e063-6294a90a8d9b2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 45W1TITANIUM DIOXIDEAmorepacific Corporation5f4335c8-596f-3269-e063-6294a90a6c3d2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 46W1TITANIUM DIOXIDEAmorepacific Corporation5f43404e-bdab-3f4b-e063-6294a90ab8812026-11-01WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.